Revolution Medicines (RVMD)

• Market cap: $7.08B
• 1 day: 1.01%
• 5 days: -0.13%
• 1 month: -2.51%
• 3 months: -13.82%
• 6 months: -13.74%
• Year to date: -13.41%
• 1 year: 20.11%
• 5 years: 69.48%
• 10 years: 31.83%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

124% more repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 55

103% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 30

21% more funds holding in top 10

Funds holding in top 10: 19 [Q3] → 23 (+4) [Q4]

10% more funds holding

Funds holding: 251 [Q3] → 276 (+25) [Q4]

8% more capital invested

Capital invested by funds: $7.85B [Q3] → $8.44B (+$597M) [Q4]

2.27% more ownership

Funds ownership: 103.59% [Q3] → 105.86% (+2.27%) [Q4]

16% less call options, than puts

Call options by funds: $42.3M | Put options by funds: $50.2M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $59 55% upside
• Avg. target: $70 84% upside
• High target: $78 105% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Robert Burns 22% 1-year accuracy 38 / 169 met price target	92% upside $73	Buy Maintained	3 Mar 2025
Stifel Benjamin Burnett 36% 1-year accuracy 5 / 14 met price target	105% upside $78	Buy Maintained	27 Feb 2025
Needham Ami Fadia 35% 1-year accuracy 59 / 170 met price target	55% upside $59	Buy Maintained	27 Feb 2025
UBS Eliana Merle 30% 1-year accuracy 6 / 20 met price target	86% upside $71	Buy Maintained	8 Jan 2025